MedPath

Gravimox

Brand Name: Gravimox

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-1092-05

Dosage Form

Powder For Suspension

Issuance Date

April 1, 2019

Expiry Date

October 14, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength312.5mg / 5mL
PackagingAmber Glass Bottle x 60mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Penicillin + Beta-lactamase Inhibitor)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform